Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer.

Anja Thronicke Thomas ReinholdPhilipp von TrottHarald Matthes Friedemann Schad

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

Based on this CEA analysis, from the hospital's point of view, the costs per mean month of OS and per mean hospital stay were lower for patients under combinational standard of care plus VA compared to patients receiving standard of care alone for the treatment of stage IV pancreatic cancer. Further prospective cost-effectiveness studies are mandatory to reevaluate our findings.

Keyphrases

healthcare
palliative care
end stage renal disease
newly diagnosed
ejection fraction
quality improvement
prognostic factors
pain management
emergency department
combination therapy
peritoneal dialysis
adverse drug
patient reported outcomes
health insurance